Reported gross profit margin and reported operating income margin were 64.0% and 10.5% in the quarter. Reported net earnings per diluted share of $0.84 increased 6.3% in the quarter. Reported net earnings of $323 million increased 7.0% in the quarter. Organic net sales increased 7.2% in the quarter including 9.5% from increased unit volume partially offset by 2.3% from lower prices.
Orthopaedics and Spine net sales of $1.9 billion increased 5.1% in the quarter and 7.2% in constant currency. Organic net sales increased 10.8% in the quarter from a 10.8% increase in unit volume. MedSurg and Neurotechnology net sales of $2.4 billion increased 10.6% in the quarter and 12.1% in constant currency. Organic net sales increased 9.2% in the quarter including 10.2% from increased unit volume partially offset by 1.0% from lower prices. "We are encouraged by the steady improvement of surgery volumes and the robust demand for our capital products however, we expect supply chain challenges to persist for much of the year."Ĭonsolidated net sales of $4.3 billion increased 8.1% in the quarter and 9.9% in constant currency. "We delivered solid first quarter results in the face of a challenging macroeconomic environment," said Kevin A.
Reported operating income margin of 10.5%.Reported net sales increased 8.1% to $4.3 billion.Stryker (NYSE:SYK) reported operating results for the first quarter of 2022:
0 kommentar(er)
